Daewoong announces partnership with Supernus Pharmaceuticals

Published: 2009-12-31 06:58:00
Updated: 2009-12-31 06:58:00
Daewoong Pharm says it has signed an exclusive agreement with the US based Supernus Pharmaceuticals Inc. to distribute a controlled-release Epliga in Korea, possibly in 2012.

Epliga, an epilepsy medicine, is a novel once-per-day dosage form of oxcarbazepine that is designed to improve complian...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.